References On Apoptosis

1. Lindenboim, L., Haviv, R., Stein, R., Inhibition of drug-induced apoptosis by survival factors in PC12 cells, JNeurochem, 64, 1054, 1995.

2. Savill, J., Apoptosis in disease, EurJClinlnvest, 24, 715, 1994.

3. Ameisen, J. C., Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer, AIDS, 8, 1197, 1994.

4. Hartsell, T. L., Hinman, L. M., Hamann, P. R., Schor, N. F., Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage, J Pharmacol Exp Therap, 277, 1158, 1996.

5. Marushige, K., Marushige, Y, Induction of apoptosis by transforming growth factor beta 1 in glioma and trigeminal neurinoma cells, Anticancer Res, 14, 2419, 1994.

6. Kim, C. J., Kim, H. O., Choe, Y. J., Lee, Y. A., Kim, C. W., Bcl-2 protein expression in neuroblastoma is differentially regulated by differentiation inducers, Anticancer Res, 15, 1997, 1995.

7. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., Steck, P. A., Roth, J. A., McDonnell, T. J., Steck, K. D., Levin, V. A., Yung, W. K., Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis, Cancer Res, 56, 694, 1996.

8. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., Vogelstein, B, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 1993.

9. Alderson, L. M., Castleberg, R. L., Harsh, G. R., 4th, Louis, D. N., Henson, J. W., Human gliomas with wild-type p53 express bcl-2, Cancer Res, 55, 999, 1995.

10. Couldwell, W. T., Hinton, D. R., Law, R. E., Protein kinase C and growth regulation in malignant gliomas, Neurosurgery, 35, 1184, 1994.

11. Couldwell, W. T., Gopalakrishna, R., Hinton, D. R., He, S., Weiss, M. H., Law, R. E., Apuzzo, M. L., Hypericin: a potential antiglioma therapy, Neurosurgery, 35, 705, 1994.

12. Marushige, Y., Marushige, K., Disappearance of ubiquinated histone H2A during chromatin condensation in TGF beta 1-induced apoptosis, Anticancer Res, 15, 267, 1995.

13. Reed, J. C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., Pleasure, D., Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin, Cancer Res, 51, 6529, 1991.

14. Krishna, M., Smith, T. W., Recht, L. D., Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy, J Neurosurg, 83, 1017, 1995.

15. Ikeda, H., Hirato, J., Akami, M., Matsuyama, S., Suzuki, N., Takahashi, A., Kuroiwa, M., Bcl-2 oncoprotein expression and apoptosis in neuroblastoma, J Pediatr Surg, 30, 805, 1995.

16. Dole, M., Nunez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., Castle, V. P. 1994 Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblas-toma, Cancer Res, 54, 3253, 1994.

17. Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Nunez, G., Castle, V. P., Bcl-X L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis, Cancer Res, 55, 2576, 1995.

18. Iwadate, Y., Fujimoto, S., Tagawa, M., Namba, H., Sueyoshi, K., Hirose, M., Sakiyama, S., Association of p53 gene mutation with decreased chemosensitiv-ity in human malignant gliomas, Int J Cancer, 69, 236, 1996.

19. Weller, M., Malipiero, U., Aguzzi, A., Reed, J. C., Fontana, A., Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation, J Clin Invest, 95, 2633, 1995.

Hoehner, J. C., Hedborg, F., Wiklund, H. J., Olsen, L., Pahlman, S., Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression, Int J Cancer, 62, 19, 1995.

Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., Bredesen, D. E., Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species, Science, 262, 1274, 1993.

Cortazzo, M., Schor, N. F., Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2, Cancer Res, 56, 1199, 1996.

Kluck, R. M., Bossy-Wetzel, E., Green, D. R., Newmeyer, D. D., The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apop-tosis, Science, 275, 1132, 1997.

Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., Wang, X., Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science, 275, 1129, 1997.

Tyurina, Y. Y., Tyurin, V. A., Carta, G., Quinn, P. J., Schor, N. F., Kagan, V. E., Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells, Arch Biochem Biophys, 344, 413, 1997.

Itano, Y., Ito, A., Uehara, T., Nomura, Y., Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: positive and negative effects of protein kinases C and A, respectively, J Neurochem, 67, 131, 1996. Cortazzo, M. H., Kassis, E. S., Sproul, K. A., Schor, N. F., Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor, J Neurosci, 16, 3895, 1996. Rabizadeh, S., Oh, J., Zhong, L.-T., Yang, J., Bitler, C. M., Butcher, L. L., Bredesen, D. E., Induction of apoptosis by the low-affinity NGF receptor, Science, 261, 345, 1993.

Shih, A., Laramee, G. R., Schmelzer, C. H., Burton, L. E., Winslow, J. W., Mu-tagenesis identifies amino-terminal residues of nerve growth factor necessary for trk receptor binding and biological activity, J Biol Chem, 269, 27679, 1994. Ibanez, C. F., Ebendal, T., Barbany, G., Murray-Rust, J., Blundell, T. L., Persson, H., Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product, Cell, 69, 329, 1992. Ikemoto, H., Tani, E., Matsumoto, T., Nakano, A., Furuyama, J, Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor, J Neurosurg, 83, 1008, 1995.

Hickman, J. A., Apoptosis induced by anticancer drugs, Cancer Metastasis Rev, 11, 121, 1992.

Langan, T. J., Volpe, J. J., Obligatory relationship between the sterol biosynthetic pathway and DNA synthesis and cellular proliferation in glial primary cultures, J Neurochem, 46, 1283, 1986.

Langan, T. J., Slater, M. C., Isoprenoids and astroglial cell cycling: diminished mevalonate availability and inhibition of dolichol-linked glycoprotein synthesis arrest cycling through distinct mechanisms, J Cell Physiol, 149, 284, 1991. Jones, K. D., Couldwell, W. T., Hinton, D. R., Su, Y., He, S., Anker, L., Law, R. E., Lovastatin induces growth inhibition and apoptosis in human malignant glio-ma cells, Biochem Biophys Res Commun, 205, 1681, 1994.

Valbo, C., Bergenheim, T., Bergh, A., Grankvist, K., Henriksson, R., DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glio-ma but not in normal brain — suggesting an apoptotic cell death, Br J Cancer, 71, 717, 1995.

37. Yin, D., Kondo, S., Barnett, G. H., Morimura, T., Takeuchi, J., Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells, Neurosurgery, 37, 758, 1995.

38. Short, M. P., Choi, B. C., Lee, J. K., Malick, A., Breakfield, X. O., Martuza, R. L, Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line, J Neurosci Res, 27, 427, 1990.

39. Maria, B. L., Medina, C. D., Gene therapy: the beginning of a new era in treating neurological disease, Internat Pediat, 11, 248, 1996.

40. Hamel, W., Magnelli, L., Chiarugi, V. P., Israel, M. A., Herpes simplex virus thymidine kinase/gancyclovir-mediated apoptotic death of bystander cells, Cancer Res, 56, 2697, 1996.

41. Ram, Z., Culver, K. W., Walbridge, S., Frank, J. A., Blaese, R. M., Oldfield, E. H., Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors, J Neurosurg, 79, 400, 1993.

42. Gshwind, M., Huber, G., Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent, J Neurochem, 65, 292, 1995.

43. Smith, T. K., Nylander, K. D., Schor, N. F., The roles of mitotic arrest and protein synthesis in induction of apoptosis and differentiation in neuroblastoma cells in culture, Dev Brain Res, 105, 175, 1998.

44. Melino, G., Annicchiarico-Petruzzelli, M., Piredda, L., Candi, E., Gentile, V., Davies, P. J. A., Piacentini, M., Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells, Mol Cell Biol, 14, 6584, 1994.

45. Tiffany-Castiglioni, E., Saneto, R. P., Proctor, P. H., Perez-Polo, J. R., Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neu-roblastoma cell line, Biochem Pharmacol, 31, 181, 1982.

46. Waters, C. M., Walkinshaw, G., Distinct pathways for induction of apoptosis in PC12 cells, Soc Neurosci Abst, 21, 2, 1995.

47. Thoenen, H., Tranzer, J. P., Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine, Naunyn-Schmiedbergs Arch Exp Pathol Pharmakol, 261, 271, 1968.

48. Uretsky, N. J., Iversen, L. L., Effects of 6-hydroxydopamine on noradrenaline-containing neurons in the rat brain, Nature (Lond), 221, 557, 1969.

49. Malmfors, T., Sachs, C., Degeneration of adrenergic nerves produced by 6-hy-droxydopamine, Eur J Pharmacol, 3, 89, 1968.

50. Schor, N. F. T., Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy, Cancer Res, 47, 5411, 1987.

51. Purpura, P., Westman, L., Will, P., Eidelman, A., Kagan, V. E., Osipov, A. N., Schor, N. F., Adjunctive treatment of murine neuroblastoma with 6-hydroxy-dopamine and Tempol, Cancer Res, 56, 2336, 1996.

52. Hahn, S. M., Tochner, Z., Murali Krishna, C., Glass, J., Wilson, L., Samuni, A., Sprague, M., Venzon, D., Glatstein, E., Mitchell, J. B., Russo, A., Tempol, a stable free radical, is a novel murine radiation protector, Cancer Res, 52, 1750, 1992.

53. Hartsell, T. L., Yalowich, J. C., Ritke, M. K., Martinez, A. J., Schor, N. F., Induction of apoptosis in murine and human neuroblastoma cell lines by the ene-diyne natural product neocarzinostatin, J Pharmacol Exp Therap, 275, 479, 1995.

54. Schor, N. F., Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin: studies in murine neuroblastoma cells, J Clin Invest, 89, 774, 1992.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment